Last update 20 Mar 2025

Recombinant human nerve growth factor(Beijing Tongren Hospital)

Overview

Basic Info

Drug Type
Growth factors
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Nervous System DiseasesEye DiseasesOther Diseases
Active Indication-
Inactive Indication
Optic Nerve Injuries
Originator Organization
Beijing Tongren HospitalBeijing Tongren Hospital
Active Organization-
Inactive Organization
Beijing Tongren HospitalBeijing Tongren Hospital
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Recombinant human nerve growth factor(Beijing Tongren Hospital)
NCT04232332
/ Unknown statusPhase 1IIT
The Phase I Study of Recombinant Human Nerve Growth Factor Injection in Healthy Chinese Volunteers on Safety, Tolerability and Pharmacokinetics: Randomized, Double-blind, Placebo-controlled, Single / Multiple Dose
100 Clinical Results associated with Recombinant human nerve growth factor(Beijing Tongren Hospital)
Login to view more data
100 Translational Medicine associated with Recombinant human nerve growth factor(Beijing Tongren Hospital)
Login to view more data
100 Patents (Medical) associated with Recombinant human nerve growth factor(Beijing Tongren Hospital)
Login to view more data
100 Deals associated with Recombinant human nerve growth factor(Beijing Tongren Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Optic Nerve InjuriesPhase 1
China
Beijing Tongren HospitalBeijing Tongren Hospital
26 Dec 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free